These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20667441)

  • 1. Strain identification of commercial influenza vaccines by mass spectrometry.
    Creskey MC; Smith DG; Cyr TD
    Anal Biochem; 2010 Nov; 406(2):193-203. PubMed ID: 20667441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC; Li C; Wang J; Girard M; Lorbetskie B; Gravel C; Farnsworth A; Li X; Smith DG; Cyr TD
    Vaccine; 2012 Jul; 30(32):4762-70. PubMed ID: 22643214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL; Pirkle JL; Barr JR
    Vaccine; 2012 Mar; 30(14):2475-82. PubMed ID: 22197963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C; Shao M; Cui X; Song Y; Li J; Yuan L; Fang H; Liang Z; Cyr TD; Li F; Li X; Wang J
    Biologicals; 2010 Mar; 38(2):284-9. PubMed ID: 20074976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted N-linked glycosylation analysis of H5N1 influenza hemagglutinin by selective sample preparation and liquid chromatography/tandem mass spectrometry.
    Blake TA; Williams TL; Pirkle JL; Barr JR
    Anal Chem; 2009 Apr; 81(8):3109-18. PubMed ID: 19290601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
    Abed Y; Hardy I; Li Y; Boivin G
    J Med Virol; 2002 Aug; 67(4):589-95. PubMed ID: 12116009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
    J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection.
    García-Cañas V; Lorbetskie B; Bertrand D; Cyr TD; Girard M
    Anal Chem; 2007 Apr; 79(8):3164-72. PubMed ID: 17361989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
    Williams TL; Luna L; Guo Z; Cox NJ; Pirkle JL; Donis RO; Barr JR
    Vaccine; 2008 May; 26(20):2510-20. PubMed ID: 18440105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture.
    Segu ZM; Hussein A; Novotny MV; Mechref Y
    J Proteome Res; 2010 Jul; 9(7):3598-607. PubMed ID: 20405899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    Chen Z; Zhou H; Jin H
    Vaccine; 2010 May; 28(24):4079-85. PubMed ID: 20399830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C; Kurata T; Tamura S
    Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.
    Veits J; Wiesner D; Fuchs W; Hoffmann B; Granzow H; Starick E; Mundt E; Schirrmeier H; Mebatsion T; Mettenleiter TC; Römer-Oberdörfer A
    Proc Natl Acad Sci U S A; 2006 May; 103(21):8197-202. PubMed ID: 16717197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
    Horimoto T; Takada A; Fujii K; Goto H; Hatta M; Watanabe S; Iwatsuki-Horimoto K; Ito M; Tagawa-Sakai Y; Yamada S; Ito H; Ito T; Imai M; Itamura S; Odagiri T; Tashiro M; Lim W; Guan Y; Peiris M; Kawaoka Y
    Vaccine; 2006 Apr; 24(17):3669-76. PubMed ID: 16378663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.